trending Market Intelligence /marketintelligence/en/news-insights/trending/Pq4MzAnXteHZCsFOyVXSVA2 content esgSubNav
In This List

Great Tree Pharmacy Q4 profit falls YOY


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


2023 Big Picture: US Consumer Survey Results


Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Great Tree Pharmacy Q4 profit falls YOY

Great Tree Pharmacy Co. Ltd. said its normalized net income for the fourth quarter was 89 Taiwan cents per share, a decline of 18.4% from NT$1.08 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$26.9 million, a decline of 12.5% from NT$30.8 million in the year-earlier period.

The normalized profit margin fell to 4.4% from 6.2% in the year-earlier period.

Total revenue grew 22.9% year over year to NT$607.8 million from NT$494.6 million, and total operating expenses increased 24.5% year over year to NT$575.3 million from NT$462.2 million.

Reported net income fell 12.8% on an annual basis to NT$35.4 million, or NT$1.16 per share, from NT$40.6 million, or NT$1.43 per share.

For the year, the company's normalized net income totaled NT$2.16 per share, a fall of 19.0% from NT$2.66 per share in the prior year.

Normalized net income was NT$61.8 million, a decrease of 15.9% from NT$73.5 million in the prior year.

Full-year total revenue rose 29.9% on an annual basis to NT$2.16 billion from NT$1.66 billion, and total operating expenses rose 33.0% on an annual basis to NT$2.10 billion from NT$1.58 billion.

The company said reported net income decreased 19.1% on an annual basis to NT$77.4 million, or NT$2.70 per share, in the full year, from NT$95.8 million, or NT$3.47 per share.

As of Feb. 18, US$1 was equivalent to NT$33.28.